Frequently Asked Questions
The market is segmented based on , By Disease Type (Myeloblastic, Promyelocytic, and Myelomonocytic), Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Others), Route of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Homecare, Speciality Centres, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) - Industry Trends and Forecast to 2030.
.
The Global Acute Myeloid Leukemia Market size was valued at USD 2500.00 USD Million in 2022.
The Global Acute Myeloid Leukemia Market is projected to grow at a CAGR of 11.3% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada, Mexico in North America, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East, Brazil, Argentina and rest of South America.
